YOLFTbeta
11

Digital Aria Co Ltd

115450 · KQ · Healthcare / Biotechnology

2,335.00KRW-55.00 (-2.30%)

Price History

Full chart

Market Stats

Previous Close2,390.00
Open2,380.00
Day Range2,325.00 – 2,460.00
52-Week Range1,342.00 – 4,160.00
Volume321.25K
Market Cap208.45B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.66
50-Day Avg2,059.34
200-Day Avg2,642.23

About

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Ki Hong Ahn
  • Employees49
  • HeadquartersParkview Office Tower, Seongnam-si, South Korea, Korea
  • Websitehttps://hlbtherapeutics.co.kr

Leadership

  • Mr. Ki Hong AhnCEO & Executive Director · b. 1967
  • Mr. Doug JangFounder

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue15.78B59.30B38.54B17.62B16.78B17.71B17.15B43.58B58.97B42.93B43.59B48.13B52.59B54.93B69.56B
Growth (%)-+275.75%-35.01%-54.28%-4.75%+5.53%-3.15%+154.10%+35.29%-27.20%+1.53%+10.43%+9.26%+4.45%+26.63%
Cost of Revenue10.92B48.61B31.19B12.67B13.54B14.42B14.59B38.17B53.47B36.35B38.45B38.82B45.23B44.73B59.39B
Gross Profit---4.61B3.24B3.30B2.56B5.41B5.50B6.58B5.13B9.31B7.36B10.20B10.17B
Gross Margin---26.17%19.32%18.61%14.94%12.42%9.32%15.32%11.78%19.35%13.99%18.57%14.62%
Operating Expense---5.48B6.40B8.37B7.17B-198.74M16.42B18.96B21.50B17.64B15.40B25.86B13.71B
Operating Income761.66M-304.79M-872.42M-3.16B-5.07B-4.61B5.61B-10.92B-12.39B-16.37B-8.33B-8.04B-15.66B-3.53B
Operating Margin4.83%-0.79%-4.95%-18.84%-28.65%-26.87%12.88%-18.52%-28.85%-37.55%-17.31%-15.28%-28.51%-5.08%
EBITDA------------4.76B6.63B-12.87B-4.55B
EBITDA Margin------------9.89%12.60%-23.43%-6.54%
Net Income----1.61B-4.30B-5.20B-4.82B4.57B-16.42B-16.90B-17.20B-11.35B-2.30B-22.79B-9.23B
Net Income Margin----9.13%-25.63%-29.36%-28.08%10.50%-27.85%-39.37%-39.46%-23.59%-4.38%-41.49%-13.26%
R&D--6.24M801.32M403.00M1.13B1.13B10.82M---63.35M---
R&D as % of Total Revenue--0.02%4.55%2.40%6.38%6.59%0.02%---0.13%---
Interest Expense0000000004.25B1.16B5.32B1.11B1.96B1.92B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.91%2.66%11.06%2.11%3.58%2.76%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets62.23B54.32B36.69B58.52B50.35B51.65B62.71B107.66B139.52B121.94B189.71B187.64B200.79B219.79B228.66B
Total Liabilities43.85B40.23B26.31B36.00B20.26B17.77B24.27B38.99B75.58B32.58B71.03B70.94B29.28B62.33B54.79B
Total Equity18.79B13.78B10.13B22.27B30.08B33.88B38.44B68.66B63.94B89.35B118.68B116.71B160.47B157.46B150.25B
Cash9.23B7.99B3.85B1.89B5.78B4.28B5.41B16.65B43.20B13.93B99.87B45.82B23.71B17.93B20.31B
Total Debt----12.39B---190.43M218.70M-----
Net Debt--------5.20B--5.88B-4.77B15.82B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.90B---5.29B-4.30B-2.72B-4.66B-3.53B-5.54B-11.65B-11.27B-8.81B3.33B1.29B-8.18B
Investing Cash Flow19.32B6.20B2.50B-10.82B548.98M-6.54B-16.45B-4.54B-15.68B-17.58B14.35B-41.93B-20.16B-35.46B-
Financing Cash Flow-4.50B-15.33B7.63B7.68B22.26B19.31B47.76B-32.43M82.85B-3.32B-5.28B28.39B-
Capital Expenditure398.31M469.58M571.21M467.26M8.96B10.81B188.92M222.70M555.61M85.54M822.87M3.40B5.76B8.74B10.07B
Free Cash Flow----------19.72B-15.20B-14.40B-2.43B-7.45B-18.24B
Dividends Paid-137.20M49.00M57.03M54.12M123.43M77.72M24.25M46.57M------
FCF to OCF---------169.26%134.91%163.43%-73.12%-578.36%223.08%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 11, 2016Mar 17, 2017May 12, 2017Aug 11, 2017Nov 10, 2017Mar 16, 2018May 11, 2018Aug 10, 2018Nov 11, 2018Feb 11, 2019May 10, 2019Aug 14, 2019Nov 14, 2019Feb 12, 2020May 12, 2020Aug 14, 2020Nov 13, 2020Mar 22, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Mar 18, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 26, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 18, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Mar 17, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025May 13, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------
EPS Actual83.5729.4187.36140.9713.3513.7368.99-2388.20-42.84-178.9111.697.28-30.65-39.78-108.29-3.1910.66-14.30-35.11-18.60-17.43-24.07-20.80-21.34-22.69-50.79-41.28-15.44-22.08-27.54-19.96-15.95388.00-151.00-75.00-49.29-37.02-427.27-27.05-268.60-124.64-235.95-44.44-112.08-41.06-108.52-63.34-61.41-97.68-100.36-17.8645.23-14.25-56.682.13-299.01-34.0222.43-53.220.79-65.267.29-49.00-100.58
Surprise----------------------------------------------------------------
Timing-----------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap208.45B
Enterprise Value202.33B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.23
Price / Book1.22
Revenue (TTM)64.45B
Gross Profit (TTM)4.02B
EBITDA-7.05B
Profit Margin-27.96%
Operating Margin-37.68%
Return on Equity-10.85%
Return on Assets-2.69%
Shares Outstanding88.14M
Shares Float70.53M
Beta-0.66
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 12, 202621:20
  • Jan 14, 202521:20
  • Dec 27, 2023207:200
  • Mar 15, 20232:1
  • Dec 28, 2022207:200
  • Dec 18, 2013751:592